News & Updates

Show Multimedia Only

BP status mediates link between kidney, vascular health biomarkers in young adults

24 Jul 2025

Mechanisms associated with early nephron-specific kidney injury biomarkers in young adults vary according to the blood pressure (BP) status, reports a study.

BP status mediates link between kidney, vascular health biomarkers in young adults

24 Jul 2025

Apremilast trims fat mass, reducing CV events in PsA

23 Jul 2025

Treatment with apremilast results in fat mass reduction among patients with psoriatic arthritis (PsA), indicating positive cardiovascular (CV) and metabolic effects, which may lower the risk of CV events, a recent study has shown.

Apremilast trims fat mass, reducing CV events in PsA

23 Jul 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

New drug applications approved by US FDA as of 1-15 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

Multicomponent intervention for improving medication adherence in hypertension falls short

22 Jul 2025

A primary care–based multicomponent intervention helps identify patients with antihypertensive medication nonadherence but does not result in improvements in adherence or blood pressure (BP), as reported in a study.

Multicomponent intervention for improving medication adherence in hypertension falls short

22 Jul 2025

Iron deficiency prevalent in ACS patients

22 Jul 2025 by

Patients with acute coronary syndromes (ACS) are prone to iron deficiency, which may lead to worse left ventricular systolic function and more inflammation, according to a study.

Iron deficiency prevalent in ACS patients

22 Jul 2025

Single-pill combination therapy prevents CVD mortality

22 Jul 2025

The use of single-pill combination (SPC) therapies can help in the prevention of cardiovascular disease (CVD) deaths, particularly in settings where uptake is currently low, suggests a study.

Single-pill combination therapy prevents CVD mortality

22 Jul 2025

Gestational hypertension may be linked to cerebral small vessel disease

21 Jul 2025

Midlife women with a history of gestational hypertension exhibit some signs of cerebral small vessel disease, according to a study.

Gestational hypertension may be linked to cerebral small vessel disease

21 Jul 2025

Early beta-blocker use prevents death in acute myocardial injury

20 Jul 2025 by

Using beta-blockers early can prevent 1-year mortality in patients with acute myocardial injury (AMI), reveals a recent study.

Early beta-blocker use prevents death in acute myocardial injury

20 Jul 2025

Pandemic fuels burden of non-COVID diseases

19 Jul 2025 by

Disease burden has significantly increased because of the COVID-19 pandemic, particularly mental health disorders, malaria in young children in the African region, and stroke and ischaemic heart disease in older adults, reports a study.

Pandemic fuels burden of non-COVID diseases

19 Jul 2025

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

16 Jul 2025

Effective antiviral therapy is crucial for achieving sustained viral clearance and improving outcomes in patients with COVID-19, particularly among immunocompromised individuals.

At the recent ESCMID Global 2025 in Vienna, Austria, Ruth Mokgokong, a pharmacologist at Pfizer, UK, presented findings from the EPIC-IC trial, highlighting the benefits of an extended nirmatrelvir-ritonavir regimen in severely immunocompromised patients with symptomatic COVID-19.

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

16 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

BP status mediates link between kidney, vascular health biomarkers in young adults

BP status mediates link between kidney, vascular health biomarkers in young adults

Apremilast trims fat mass, reducing CV events in PsA

Apremilast trims fat mass, reducing CV events in PsA

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

Multicomponent intervention for improving medication adherence in hypertension falls short

Multicomponent intervention for improving medication adherence in hypertension falls short

Iron deficiency prevalent in ACS patients

Iron deficiency prevalent in ACS patients

Single-pill combination therapy prevents CVD mortality

Single-pill combination therapy prevents CVD mortality

Gestational hypertension may be linked to cerebral small vessel disease

Gestational hypertension may be linked to cerebral small vessel disease

Early beta-blocker use prevents death in acute myocardial injury

Early beta-blocker use prevents death in acute myocardial injury

Pandemic fuels burden of non-COVID diseases

Pandemic fuels burden of non-COVID diseases

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19

Nirmatrelvir-ritonavir shows benefits in immunocompromised individuals with COVID-19